Department of Pharmacology and Pharmacognosy, School of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, Kenya.
Department of Pharmacology and Pharmacognosy, College of Health Sciences, University of Nairobi, Nairobi, Kenya.
BMC Complement Med Ther. 2022 Feb 25;22(1):49. doi: 10.1186/s12906-022-03532-1.
Acquired immunodeficiency syndrome (AIDS) is a clinical syndrome resulting from infection with human immunodeficiency virus (HIV), which causes profound immunosuppression. Anti-HIV drugs that are currently available are chemically synthesized and are frequently limited by side effects, the emergence of drug resistance, affordability, and availability, with over 5 million people in the world lacking access to treatment. As a result, to discover new anti-HIV agents, we investigated the effects of Kenyan C. dichogamus extracts on the laboratory-adapted strain HIV-1 in human T-lymphocytic MT-4 cells.
Four soluble fractions of 1:1 v/v CHCl:MeOH extract of the twigs of C. dichogamus Pax were tested for their replication inhibition activity against the laboratory-adapted strain HIV-1 in the human T-lymphocytic MT-4 cell line. The plant extracts were further evaluated for their cytotoxicity in MT-4 cells using the MTT assay.
The cytotoxicity CC values of the methanol and methylene chloride soluble fractions of C. dichogamus were found to be between 19.58 ± 0.79 and 167 ± 0.8 µg/ml, respectively. The hexane, methylene chloride, and methanol soluble fractions of the 1:1 v/v CHCl:MeOH extract of the twigs of C. dichogamus showed inhibition of the HIV-1 laboratory-adapted strain in a virus-infected cell culture antiviral assay. The methanol soluble fraction of the 1:1 v/v CHCl:MeOH extract of the twigs of C. dichogamus showed significant anti-HIV activity by inhibiting more than 90% of viral-induced cytopathic effects with an IC value of 0.06 ± 0.01 µg/ml, giving an SI of 318.5.
Based on our findings, the methanol soluble fraction of the 1:1 v/v CHCl:MeOH extract of the twigs of C. dichogamus has shown potential efficacy in inhibiting viral replication and could be considered a promising candidate for further studies.
艾滋病(AIDS)是一种由人类免疫缺陷病毒(HIV)感染引起的临床综合征,会导致严重的免疫抑制。目前可用的抗 HIV 药物是化学合成的,经常受到副作用、耐药性出现、可负担性和可及性的限制,全球有超过 500 万人无法获得治疗。因此,为了发现新的抗 HIV 药物,我们研究了肯尼亚 C. dichogamus 提取物对实验室适应株 HIV-1 在人 T 淋巴细胞 MT-4 细胞中的影响。
测试了 C. dichogamus Pax 小枝 1:1v/v CHCl:MeOH 提取物的 4 种可溶性部分对人 T 淋巴细胞 MT-4 细胞系中实验室适应株 HIV-1 的复制抑制活性。使用 MTT 测定法进一步评估植物提取物对 MT-4 细胞的细胞毒性。
C. dichogamus 的甲醇和亚甲基氯可溶性部分的细胞毒性 CC 值分别为 19.58±0.79 和 167±0.8µg/ml。C. dichogamus 1:1v/v CHCl:MeOH 提取物的正己烷、亚甲基氯和甲醇可溶性部分在病毒感染细胞培养抗病毒测定中显示出对 HIV-1 实验室适应株的抑制作用。C. dichogamus 1:1v/v CHCl:MeOH 提取物的甲醇可溶性部分对病毒诱导的细胞病变效应具有显著的抗 HIV 活性,抑制率超过 90%,IC 值为 0.06±0.01µg/ml,SI 为 318.5。
根据我们的发现,C. dichogamus 1:1v/v CHCl:MeOH 提取物的甲醇可溶性部分在抑制病毒复制方面显示出潜在的疗效,可被视为进一步研究的有前途的候选药物。